Camille Duluc

483 total citations
5 papers, 290 citations indexed

About

Camille Duluc is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Camille Duluc has authored 5 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Camille Duluc's work include Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Lung Cancer Research Studies (2 papers). Camille Duluc is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Lung Cancer Research Studies (2 papers). Camille Duluc collaborates with scholars based in France, Switzerland and Morocco. Camille Duluc's co-authors include Corinne Bousquet, Stéphane Pyronnet, Rémi Samain, Muriel Mathonnet, Herbert Schmid, Yvan Martineau, Marie‐Bernadette Delisle, Mounira Chalabi‐Dchar, Aurélie Perraud and Marion Gayral and has published in prestigious journals such as Gastroenterology, Trends in Endocrinology and Metabolism and Oncotarget.

In The Last Decade

Camille Duluc

5 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Camille Duluc France	4	200	109	72	63	57	5	290
Jarmila Stremenova Spegarova Czechia	10	162 0.8×	80 0.7×	19 0.3×	62 1.0×	45 0.8×	12	259
Lisa Blaydorn United States	6	290 1.4×	78 0.7×	38 0.5×	59 0.9×	89 1.6×	8	386
Libenzio Adrian Conti Italy	8	96 0.5×	185 1.7×	30 0.4×	83 1.3×	158 2.8×	12	339
Veronica Bonasera Italy	5	228 1.1×	152 1.4×	21 0.3×	44 0.7×	25 0.4×	5	375
Roberto Arrojo United States	5	308 1.5×	133 1.2×	19 0.3×	36 0.6×	28 0.5×	11	392
Sarah Skuli United States	7	69 0.3×	221 2.0×	39 0.5×	94 1.5×	30 0.5×	15	314
Yukari Okita Japan	9	110 0.6×	155 1.4×	22 0.3×	57 0.9×	39 0.7×	16	273
G. Scott Chandler United States	8	184 0.9×	78 0.7×	24 0.3×	40 0.6×	56 1.0×	19	270
Martina Tufano Italy	9	102 0.5×	108 1.0×	20 0.3×	31 0.5×	92 1.6×	19	264
Benjamin Kühnemuth Germany	8	167 0.8×	119 1.1×	23 0.3×	56 0.9×	122 2.1×	11	293

Countries citing papers authored by Camille Duluc

Since Specialization

Citations

This map shows the geographic impact of Camille Duluc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Duluc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Duluc more than expected).

Fields of papers citing papers by Camille Duluc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Duluc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Duluc. The network helps show where Camille Duluc may publish in the future.

Co-authorship network of co-authors of Camille Duluc

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Duluc. A scholar is included among the top collaborators of Camille Duluc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Duluc. Camille Duluc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Duluc, Camille, Rémi Samain, Christine Jean, et al.. (2016). Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts. Oncotarget. 7(27). 41584–41598. 32 indexed citations

2.

Duluc, Camille, Mounira Chalabi‐Dchar, Aurélie Perraud, et al.. (2015). Pharmacological targeting of the protein synthesis mTOR /4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance. EMBO Molecular Medicine. 7(6). 735–753. 167 indexed citations

3.

Chalabi‐Dchar, Mounira, Stéphanie Cassant‐Sourdy, Camille Duluc, et al.. (2015). Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. Gastroenterology. 148(7). 1452–1465. 35 indexed citations

4.

Duluc, Camille, Philippe Caron, Delphine Vezzosi, et al.. (2014). Somatostatin analogs: does pharmacology impact antitumor efficacy?. Trends in Endocrinology and Metabolism. 25(3). 115–127. 55 indexed citations

5.

Duluc, Camille, Yvan Martineau, Barbara Garmy‐Susini, et al.. (2014). Targeting cancer-associated fibroblasts through inhibition of protein synthesis to abrogate resistance to chemotherapies in pancreatic cancer. Pancreatology. 14(3). S72–S72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact